within Pharmacolibrary.Drugs.ATC.D;

model D10AX03
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D10AX03</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Azelaic acid is a naturally occurring dicarboxylic acid used topically as a medication primarily for the treatment of mild to moderate acne and rosacea. It works as an antimicrobial and anti-inflammatory agent and is approved for current therapeutic use by various regulatory agencies.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data for azelaic acid in published literature is extremely limited due to its predominantly topical route of administration, resulting in minimal systemic absorption. Available reports suggest very low systemic bioavailability with topical use in healthy adults.</p><h4>References</h4><ol><li><p>Fitton, A, &amp; Goa, KL (1991). Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. <i>Drugs</i> 41(5) 780–798. DOI:<a href=\"https://doi.org/10.2165/00003495-199141050-00007\">10.2165/00003495-199141050-00007</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1712709/\">https://pubmed.ncbi.nlm.nih.gov/1712709</a></p></li><li><p>Sauer, N, et al., &amp; Karłowicz-Bodalska, K (2023). The multiple uses of azelaic acid in dermatology: mechanism of action, preparations, and potential therapeutic applications. <i>Postepy dermatologii i alergologii</i> 40(6) 716–724. DOI:<a href=\"https://doi.org/10.5114/ada.2023.133955\">10.5114/ada.2023.133955</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38282869/\">https://pubmed.ncbi.nlm.nih.gov/38282869</a></p></li><li><p>Gollnick, H, &amp; Layton, A (2008). Azelaic acid 15% gel in the treatment of rosacea. <i>Expert opinion on pharmacotherapy</i> 9(15) 2699–2706. DOI:<a href=\"https://doi.org/10.1517/14656566.9.15.2699\">10.1517/14656566.9.15.2699</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18803456/\">https://pubmed.ncbi.nlm.nih.gov/18803456</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D10AX03;
